Thousands of patients prescribed high-risk drugs

Thousands of patients in Scotland who are particularly vulnerable to adverse drug events (ADEs) were prescribed high-risk medications by their GPs which could potentially cause them harm, according to research published in the British Medical Journal today.

Although at least some of this prescribing will be appropriate because prescribers and patients are balancing risks and benefits when there may be no clearly 'correct' course of action, the study also finds that there was significant variation in the prescribing practices between the GPs surgeries surveyed. This variation could not be explained by the patient case mix which suggests that there is considerable scope to improve prescribing practices, say the researchers.

The authors, led by Professor Bruce Guthrie from Dundee University, say that previous studies have shown that GP prescribing can cause considerable harm, and they highlight that "adverse drug events (ADEs) account for 6.5% of all , over half of which are judged to be preventable".

Patients could be vulnerable to high risk drugs because of their age, other existing illnesses or because of other they may be on. GPs need to be alert to these risk factors and be cautious about the drugs they prescribe to these patients, say the authors.

A number of medications or scenarios are already flagged up as high risk, for example, for certain patients, prescribing a new drug when a patient is on the blood-thinning medication warfarin, prescribing drugs when patients have and prescribing for patients who have dementia.

Guthrie and colleagues expanded the list above and developed 15 indicators to examine how often patients vulnerable to ADEs were prescribed high-risk medication that could harm them.

The authors used the indicators to review data from 315 Scottish General Practices with 1.76 million patients, of which 139,404 (7.9%) were identified as being particularly vulnerable to ADEs.

The results show that 19,308 (13.9%) who were in the vulnerable group were prescribed one or more high-risk medications.

While the authors emphasise that not all high-risk prescribing is inappropriate they conclude that the study shows "that opportunities to improve primary care prescribing safety are considerable" across the UK.

Related Stories

Physicians click their way to better prescriptions

date Mar 10, 2010

Is it time for all community-based doctors to turn to e-prescribing to cut down on the number of medication errors? According to Rainu Kaushal and colleagues from the Weill Cornell Medical College in New York, electronic ...

Recommended for you

Study supports HPV vaccination guidelines

date 8 hours ago

(HealthDay)—New research finds that young women who get the HPV vaccine gain significant protection against infection in three parts of the body if they haven't already been exposed to the human papillomavirus.

Teva offers to buy Mylan in $40.1B cash-and-stock deal

date 12 hours ago

Generic drug giant Teva formally offered to buy fellow drugmaker Mylan for about $40.1 billion in cash and stock on Tuesday, despite Mylan's cold shoulder and the certainty the proposed acquisition will bring ...

FDA warns of bogus botox

date Apr 20, 2015

(HealthDay)—Counterfeit Botox may have been distributed to doctors' offices and medical clinics across the United States, the U.S. Food and Drug Administration warns.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.